Furthermore, CK treatment demonstrated that TP53 suppression inhibited adipocyte and enhanced osteoblast differentiation in vitro, suggesting that p53 aided in the pathological advancement of obesogenesis and osteoporosis. The gene discussed is TP53; the disease is osteoporosis.